SCHEMBL516901

SCHEMBL516901

O=S(=O)(O)c1cc2ccccc2[nH]1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.67
AKR1B1 P15121 1/20 0.50
FLT3 P36888 1/20 0.50
DAO P14920 2/20 0.48
KDM4E B2RXH2 2/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
SRD5A2 P31213 1/20 0.48
HSD17B10 Q99714 1/20 0.48
DDO Q99489 1/20 0.48
CNR1 P21554 4/20 0.48
L3MBTL1 Q9Y468 1/20 0.46
CYP2A6 P11509 1/20 0.46
AOC3 Q16853 2/20 0.45
BRD4 O60885 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA9 Q16790 1/20 0.44
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29560278 1.00 CA2 (0.67) CA2AKR1B1FLT3DAOKDM4E
Hydrochloric Acid SCHEMBL27675573 0.98 CA2 (0.65) CA2AKR1B1FLT3DAOKDM4E
SCHEMBL15646965 0.98 CA2 (0.65) CA2AKR1B1FLT3DAOKDM4E
Cyanide SCHEMBL28945747 0.94 CA2 (0.61) CA2AKR1B1FLT3DAOKDM4E
Carbazole SCHEMBL28036002 0.93 CA2 (0.59) CA2AKR1B1FLT3DAOKDM4E
Alcohol SCHEMBL28254229 0.91 CA2 (0.57) CA2AKR1B1FLT3DAOKDM4E
Pyridine SCHEMBL29650329 0.88 CA2 (0.54) CA2AKR1B1FLT3DAOKDM4E
SCHEMBL28568569 0.83 CA2 (0.71) CA2AKR1B1FLT3DAOKDM4E
SCHEMBL329510 0.82 CA2 (0.69) CA2AKR1B1FLT3DAOKDM4E
SCHEMBL25418533 0.81 CA2 (0.62) CA2AKR1B1FLT3DAOKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119390777-A Zwitterionic fluorescent probe containing dimeric targeting ligand and preparation method and application thereof 北京声光纳医疗科技有限公司 2025-02-07 CN claimed
CN-119390778-A Zwitterionic fluorescent probe based on click chemistry reaction and preparation method and application thereof 北京声光纳医疗科技有限公司 2025-02-07 CN claimed
CN-116891479-B Response half-cyanine fluorescent probe for targeting MOR, and synthesis method and application thereof 中国药科大学 2024-04-19 CN claimed
CN-117089342-A Preparation and application of cellulose paper composite indole derivative fluorescent platform for detecting picric acid 南京林业大学 2023-11-21 CN claimed
CN-116891479-A Response half-cyanine fluorescent probe for targeting MOR, and synthesis method and application thereof 中国药科大学 2023-10-17 CN claimed
CN-116253673-A Indole sulfonated monomer, indole sulfonated polymer, proton exchange membrane and preparation method thereof 南阳师范学院 2023-06-13 CN claimed
CN-102574102-B For conjugated protein and peptide specific adsorption agent and use its separation method Yin Siqi Aikeshi Co.,Ltd. (DE) 2015-11-25 CN claimed
CN-102574102-A Specific sorbent for binding proteins and peptides, and separation method using the same NSTRACTION GMBH 2012-07-11 CN claimed
EP-1986701-B1 OPTICAL AGENTS FOR USE IN SURGERY MALLINCKRODT LLC (US) 2012-06-13 EP claimed
US-20080167348-A1 NOVEL SULFONAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2008-07-10 US claimed
CN-1399638-A Indolocaza * useful as vasopressin receptor antagonists ORTHO MCNEIL PHARM INC (US) 2003-02-26 CN claimed
JP-10025595-A None JP disclosed
CN-121226357-A Indole sulfonic acid-phenothiazine fluorescent probe and preparation method and application thereof 青岛科技大学 2025-12-30 CN disclosed
US-20250383357-A1 NOVEL FLUORESCENT DYES AND POLYMERS FROM DIHYDROPHENANTHRENE DERIVATIVES BECKMAN COULTER INC (US) 2025-12-18 US disclosed
US-12473360-B2 Multi-specific antibody constructs BIOATLA, INC. (US) 2025-11-18 US disclosed
WO-2002032464-A1 NOVEL DYES FOR ORGAN FUNCTION MONITORING MALLINCKRODT INC. (US) 2002-04-25 WO disclosed
WO-2002032421-A1 INDOLE COMPOUNDS AS MINIMALLY PHYSIOLOGIAL FUNCTION MONITIORING AGENTS MALLINCKRODT INC. (US) 2002-04-25 WO disclosed
CN-1275977-A Heterocyclic thioesters and ketones GPI NIL HOLDING CO (US) 2000-12-06 CN disclosed
CN-1213315-A Composition for inhibiting cell growth comprising calcium influx blocker WELLESLEY CENTRAL HOSPITAL (CA) 1999-04-07 CN disclosed
JP-H1025595-A TIN AND TIN ALLOY PLATING BATH ISHIHARA CHEM CO LTD 1998-01-27 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080167348-A1 NOVEL SULFONAMIDE DERIVATIVES CMA1, ARSA, TPSAB1 CA2 17/4885AKR1B1 707/4885FLT3 1783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.